Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Qixian Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5113809894. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Tumor-Derived LAMB3 Drives Immunosuppressive LRRC15+ Fibroblast Formation During Pancreatic Ductal Adenocarcinoma Development. Co-author DOI 10.1002/advs.202520029↗
  2. LINC01963 promotes pancreatic ductal adenocarcinoma proliferation via METTL3/IGF2BP2 axis-mediated m⁶A modification of c-Myc. Co-author DOI 10.1186/s13046-026-03650-5↗
  3. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12885-023-10678-9↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Liang · 3 shared papers, 2023–2026 · strength 0.72
  2. Huanwen Wu · 2 shared papers, 2023–2026 · strength 0.48
  3. Hangqi Liu · 2 shared papers, 2026 · strength 0.46
  4. Xiaoding Liu · 2 shared papers, 2026 · strength 0.46
  5. Ruiyu Li · 1 shared paper, 2023 · strength 0.26
  6. Junliang Lu · 1 shared paper, 2026 · strength 0.22
  7. Xuqing Shi · 1 shared paper, 2026 · strength 0.22
  8. Menghua Dai · 1 shared paper, 2026 · strength 0.22

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.